Glycemic Evaluation of Novel Staple Foods

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

May 19, 2023

Study Completion Date

May 19, 2023

Conditions
Diabete Type 2Diabetes Mellitus
Interventions
DIETARY_SUPPLEMENT

Modified Functional Foods

"Subjects will be provided with ABREP-fortified bread, microfluidic co-flow noodles, and 5ibrePlus™-fortified white rice served in a mixed meal.~ABREP-fortified bread: Anthocyanins are known to exert anti-diabetic effects through modulating digestion, glucose uptake, insulin secretion and sensitivity. Moreover, inhibitory effects of anthocyanins on various carbohydrases, including a-glucosidase and a-amylase have been widely reported.~Microfluidic co-flow noodles: Microfluidic technology is employed to design noodle-food structures consisting of a mix of soy protein isolate and alginate as gelling agents to offer a type of novel noodles with proteins and negligible carbohydrate content.~5ibrePlus™-fortified white rice: 5ibrePlus™ is a patented novel fibre grain product by Alchemy Foodtech Pte. Ltd (WO 2017/142477) with reduced GI. Its main constituents are insoluble resistant starch and soluble fibre."

DIETARY_SUPPLEMENT

Control Functional Foods

Subjects will be provided with control function foods including white bread, beehoon noodles, and jasmine white rice served in a mixed meal.

Trial Locations (1)

118177

National University of Singapore, Singapore

All Listed Sponsors
lead

National University of Singapore

OTHER

NCT05399134 - Glycemic Evaluation of Novel Staple Foods | Biotech Hunter | Biotech Hunter